Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
1.430
+0.020 (1.42%)
At close: Sep 9, 2026, 4:00 PM EDT
1.410
-0.020 (-1.40%)
After-hours: Sep 9, 2026, 6:54 PM EDT
Exicure Employees
Exicure had 1 employees as of June 30, 2026. The number of employees decreased by 7 or -87.50% compared to the same quarter last year.
Employees
1
Change
-7
Growth
-87.50%
Revenue / Employee
n/a
Profits / Employee
-$8,284,000
Market Cap
9.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1 | -7 | -87.50% |
| Mar 31, 2026 | 2 | -6 | -75.00% |
| Dec 31, 2025 | 8 | 1 | 14.29% |
| Mar 31, 2025 | 8 | 3 | 60.00% |
| Dec 31, 2024 | 7 | 1 | 16.67% |
| Sep 30, 2024 | 6 | 0 | - |
| Jun 30, 2024 | 5 | -2 | -28.57% |
| Mar 31, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 6 | -7 | -53.85% |
| Sep 30, 2023 | 6 | -31 | -83.78% |
| Jun 30, 2023 | 7 | -32 | -82.05% |
| Mar 31, 2023 | 9 | -31 | -77.50% |
| Dec 31, 2022 | 13 | -34 | -72.34% |
| Sep 30, 2022 | 37 | -40 | -51.95% |
| Jun 30, 2022 | 39 | -39 | -50.00% |
| Mar 31, 2022 | 40 | -26 | -39.39% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Senti Biosciences Holdings | 39 |
| Imunon | 20 |
| Soligenix | 14 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| CDT Equity | 4 |
XCUR News
- 5 weeks ago - Exicure to settle GPCR Therapeutics milestone payment through equity issuance - TheFly
- 5 weeks ago - Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - GlobeNewsWire
- 2 months ago - Exicure Announces Board and Committee Changes - GlobeNewsWire
- 3 months ago - Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement - GlobeNewsWire
- 3 months ago - Exicure receives noncompliance notification from Nasdaq - TheFly
- 3 months ago - Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q - GlobeNewsWire
- 4 months ago - Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) - GlobeNewsWire
- 5 months ago - Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions - GlobeNewsWire